Influences of Over-Expression of VEGF-C and Its Inhibition on Biological Characteristics of NCI-H446 Human Small-Cell Lung Cancer Cells

ZHANG Jie,CHEN Mo,ZHOU Cai-cun,XU Jian-fang,ZHAO Yin-min,SU Bo
DOI: https://doi.org/10.3781/j.issn.1000-7431.2012.02.001
2012-01-01
Tumori
Abstract:Objective: To investigate the influences of vascular endothelial growth factor C (VEGF-C) on cell proliferation, invasion and apoptosis of NCI-H446 human small-cell lung cancer (SCLC) cells in vitro. Methods: The plasmids for VEGF-C overexpression (pHRi-VEGF-C) and small RNA interference targeting VEGF-C (pHRi-siVEGF-C) were constructed. Then the NCI-H446 cells were infected with the lentiviral packaging plasmids pHRi (an empty vector), pHRi-VEGF-C and pHRi-siVEGF-C, respectively. The expression of VEGF-C was examined by Western blotting; the cell proliferation was detected by MTT method; the invasive ability was detected by Transwell assay; and the apoptosis rate was determined by flow cytometry (FCM). Results: The expression level of VEGF-C protein in the NCI-H446 cells was significantly increased after lentiviral packaging plasmid pHRi-VEGF-C infection while it was significantly decreased after lentiviral packaging plasmid pHRi-siVEGF-C infection. The cell proliferation was significantly increased after the NCI-H446 cells were infected with pHRi-VEGF-C for five days as compared with that of the NCI-H446 cells infected with pHRi-siVEGF-C or pHRi (1.481±0.056, 0.838±0.035 and 1.146±0.07; P < 0.05). The average number of invasive cells in each visual field was significantly reduced in the pHRi-siVEGF-C-infected NCI-H446 cells as compared with that of the pHRi-VEGF-C- or pHRi-infected NCI-H446 cells (39.78±0.77, 84.87±1.27 and 60.82±1.05; P < 0.01). The number of apoptotic cells was also reduced by 90% in the pHRi-VEGF-C-infected NCI-H446 cells as compared with that of the pHRi-infected NCI-H446 cells (P < 0.01). Conclusion: The overexpression of VEGF-C can obviously promote the proliferative and invasive abilities of NCI-H446 cells, and it also can reduce the apoptosis. Meanwhile, these effects can be inhibited by small RNA interference targeting VEGF-C. The results suggest that VEGF-C may become a target of gene treatment for small-cell lung cancer. DOI:10.3781/j.issn.1000-7431.2012.02.001
What problem does this paper attempt to address?